By PR Newswire
August 10, 2026 | 11:54
The 11th CWIEME Shanghai, APAC's leading coil winding show, concluded with record international growth after running from 24-26 June, focusing on EV, humanoid robots and eVTOL industrial applications.
By PR Newswire
August 10, 2026 | 11:51
KT&G launched its global brand ESSE at Istanbul Airport duty-free, one of the world's largest duty-free markets, reinforcing the company's global brand footprint.
By PR Newswire
August 10, 2026 | 11:45
The 5th Taroko Mountain Market will take place 15-16 August, featuring six tribal communities performing in rotation to showcase Taroko's cultural charm as the region's tourism rebounds following the earthquake.
By PR Newswire
August 10, 2026 | 11:43
Agoda highlighted Asia's premier destinations for the growing "glow-cation" trend, a travel style focused on beauty treatments and wellness experiences, citing the region's cutting-edge beauty innovations.
By PR Newswire
August 10, 2026 | 11:40
Agoda identified Goyang, Daejeon, Jeongseon, Suwon and Seoul as South Korea's most popular bakery tourism destinations, driven by growing search interest in bread pilgrimage travel.
By PR Newswire
August 10, 2026 | 11:37
Riyue Bay in Wanning, Hainan Province, is stepping into a new cultural-tourism landmark with its "Surf-Plus" concept, drawing wave-chasing visitors to the coastal destination, according to a People's Daily report.
By PR Newswire
August 10, 2026 | 11:24
More than 10,000 financial insurance professionals from around the world gathered in Hong Kong for the 16th Worldwide Chinese Life Insurance Congress and 2026 International Dragon Award Annual Conference.
By PR Newswire
August 10, 2026 | 11:16
Shandong HiTHIUM held its production rollout ceremony on 7 August for the world's first long-duration energy storage integrated industrial park in Heze Luxi New Area, marking a new phase of scalable manufacturing delivery.
By PR Newswire
August 10, 2026 | 11:12
Mabwell, dual-listed under 688062.SH and 02493.HK, announced its subsidiary T-mab passed the Brazilian Health Regulatory Agency's GMP inspection for its denosumab injections, marking a second PIC/S GMP certification.
By PR Newswire
August 10, 2026 | 11:08
RiboX Therapeutics received FDA IND clearance for RXIM002, the first circular RNA-based in vivo CAR therapy for autoimmune cytopenias, supporting the initiation of its Phase 1 clinical trial.